Navigation Links
Strongest proof yet found for prion hypothesis

UTMB scientists offer strongest evidence yet that infectious misformed proteins cause mad cow disease and other mysterious brain disorders

Researchers at the University of Texas Medical Branch at Galveston (UTMB) have produced the strongest proof yet that the mysterious and devastating brain diseases known as "transmissible spongiform encephalopathies" (TSEs) are transmitted by an infectious agent composed only of a malformed protein, and not a virus. TSEs, which can afflict both human beings and animals, include mad cow disease, new-variant Creutzfeldt-Jakob Syndrome, scrapie, kuru and chronic wasting disease.

This controversial "prion hypothesis" was proposed by Stanley Prusiner in 1982, and led to Prusiner receiving the Nobel Prize in Medicine in 1997. Until now, however, scientists have been unable to confirm its validity by causing a TSE in normal lab animals by infecting them with malformed proteins (dubbed "prions" by Prusiner) created entirely in a test tube. Such an approach eliminates the possibility that some other agent might be causing the disease.

In a paper scheduled to appear in the journal Cell on April 21, the UTMB researchers describe the use of a method they developed called "protein misfolding cyclic amplification" (PMCA) to vastly accelerate the activity of a small number of prions taken from infected hamsters and placed in test tubes containing healthy brain proteins. When the healthy proteins had been largely transformed into prions, the samples were diluted over and over again and the process repeated, until the only remaining prions were those that had been generated in the test tubes. These were then injected into the brains of healthy hamsters, which began showing TSE symptoms within four months and, on average, died less than six months after inoculation.

"For many years, people have tried to make these infectious prions in test tubes, because what is needed to prove the prion hypothesis completely is to be able to produce this process in vitro in the absence of living cells and thus rule out the presence of a virus," said Claudio Soto, professor of neurology at UTMB and senior author of the paper. "The evidence in favor of the prion hypothesis was strong, but the final proof was still missing. Now we have supplied this proof."

Soto emphasized that a tremendous increase in efficiency of the PMCA technology played a crucial role in the work of his team, which included study co-authors Joaquín Castilla, Paula Saá and Claudio Hetz. By mimicking the natural mechanism of prion formation but doing so at a much higher rate, PMCA made it possible to produce the large quantities of prion protein necessary for the success of the experiments and opened the door to further TSE studies. According to Soto, it should also soon facilitate creating a much-needed blood test for prions, which would greatly improve current surveillance techniques for mad cow disease and its human form, new-variant Creutzfeldt-Jakob Syndrome.


'"/>

Source:University of Texas Medical Branch


Related biology news :

1. Experiments provide proof of how traveling in groups protects insects
2. Experiments provide proof of how traveling in groups protects insects
3. Scientists find fossil proof of Egypts ancient climate
4. Researchers offer proof-of-concept for Altered Nuclear Transfer
5. New component of the brakes on nerve regeneration found
6. A puzzle piece found in unraveling the wiring of the brain
7. New World founders small in number
8. Norovirus found to cause travelers diarrhea
9. Pair of cancer genes found to drive both cell migration and division
10. Alien woodwasp, threat to US pine trees, found in N.Y.
11. Achilles heel of the herpes virus possibly found
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2017)... 7, 2017 Ipsidy Inc. ( ... [OTC: IDGS], ("Ipsidy" or the "Company") a provider of ... services, is pleased to announce the following changes as ... Effective January 31, 2017, Philip D. Beck ... and President.  An experienced payment industry professional and public ...
(Date:2/3/2017)...  Texas Biomedical Research Institute announced that its Board of ... as the Institute,s new President and CEO. Dr. Schlesinger will ... He is currently the Chair of the Department of Microbial ... Interface Biology at Ohio State University. "We are ... CEO of Texas Biomed," said Dr. James O. Rubin ...
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... ... 22, 2017 , ... Pharma and biotech consulting firm ... Operating from Pennside’s Zurich headquarters, Pennside Partners, GmbH, Mr. Perkins brings 14 years ... than a decade with leading market research firm, GfK. He began his pharma ...
(Date:2/22/2017)... Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017 ... ) today announced its financial results for the ... "Our annual 2016 financial results reflect continued ... earnings exceeded $700 million," said Martine Rothblatt, Ph.D., ... financial results strengthen our ability to develop and ...
(Date:2/21/2017)... , Feb. 21, 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" ... and operational results for the three months ended December 31, ... -based life sciences and diagnostics company that develops and ... ... continue to build on the commercial milestones achieved in fiscal ...
(Date:2/21/2017)... ... February 21, 2017 , ... Vortex Biosciences announced ... automated benchtop system for collecting intact circulating tumor cells (CTCs) that are shed ... Medicine Tri Conference (Tri-Con) Annual Meeting 2017 (February 19–24 San Francisco). , The ...
Breaking Biology Technology: